18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report

Positron emission tomography computed tomography (PET-CT) using 18-Fluoro-deoxyglucose (18FDG) is an imaging modality that reflects cellular glucose metabolism. Most cancers show an uptake of 18FDG and benign tumors do not usually behave in such a way. The authors report herein the case of a 38-year-old female patient with a past medical history of cervical intraepithelial neoplasia and pheochromocytoma, in whom a liver lesion had been detected with PET-CT. The tumor was laparoscopically resected and the diagnosis of inflammatory hepatic adenoma was confirmed. This is the first description of an inflammatory hepatic adenoma with an 18FDG up-take.

[1]  J. V. Campos,et al.  [Hepatocellular adenoma]. , 2020, AMB : revista da Associacao Medica Brasileira.

[2]  Adarsh Vijay,et al.  Hepatocellular adenoma: An update. , 2015, World journal of hepatology.

[3]  W. Jarnagin,et al.  PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  S. Baba,et al.  Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2). , 2014, Clinical imaging.

[6]  R. Hustinx,et al.  Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. , 2014, World journal of gastroenterology.

[7]  S. Berlangieri,et al.  FDG PET/CT in the liver: lesions mimicking malignancies , 2014, Abdominal Imaging.

[8]  C. Chan,et al.  Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. , 2013, World journal of gastroenterology.

[9]  A. Girma,et al.  Problème diagnostique posé par une lésion hépatique hypermétabolique en TEP à la fluorocholine (18F) : à propos d’un cas , 2013 .

[10]  O. Couturier,et al.  Unusual uptake of 18FDG by a hepatic adenoma. , 2013, Clinical nuclear medicine.

[11]  M. Gulluoglu,et al.  Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. , 2012, Clinical nuclear medicine.

[12]  A. McIntosh,et al.  Loss of liver FA binding protein significantly alters hepatocyte plasma membrane microdomains[S] , 2012, Journal of Lipid Research.

[13]  A. Dennison,et al.  Uptake of 18FDG by a Hepatic Adenoma on Positron Emission Tomography , 2011, Case reports in hepatology.

[14]  Soon-Young Song,et al.  F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images. , 2011, Clinical nuclear medicine.

[15]  D. Jain,et al.  Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance , 2011, Pathology research international.

[16]  C. Dejong,et al.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  D. Pezet,et al.  Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. , 2010, Gastroenterologie clinique et biologique.

[18]  J. Zucman‐Rossi,et al.  Subtype Classification of Hepatocellular Adenoma , 2010, Digestive Surgery.

[19]  S. Fanti,et al.  C-11 Acetate Does Not Enhance Usefulness of F-18 FDG PET/CT in Differentiating Between Focal Nodular Hyperplasia and Hepatic Adenoma , 2009, Clinical nuclear medicine.

[20]  Feng Lu,et al.  Primary hepatic tuberculoma appears similar to hepatic malignancy on F-18 FDG PET/CT. , 2009, Clinical nuclear medicine.

[21]  L. Barthelmes,et al.  Liver cell adenoma and liver cell adenomatosis. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[22]  Hong-Mei Yu,et al.  [Laparoscopic liver resection for benign liver tumors]. , 2004, Zhonghua yi xue za zhi.

[23]  Jin Kim,et al.  [Evaluation of various hepatic lesions with positron emission tomography]. , 2002, Taehan Kan Hakhoe chi = The Korean journal of hepatology.

[24]  H. Alibazoglu,et al.  'False-positive' uptake of FDG in a hepatic adenoma. , 1997, Clinical nuclear medicine.

[25]  O. Couturier,et al.  Unusual Uptake of FDG by a Hepatic Adenoma , 2013 .

[26]  M. Moriguchi,et al.  Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case , 2011, Surgery Today.

[27]  R. Hustinx,et al.  Hepatobiliary disease : primary and metastatic liver tumours , 2007 .